PMV Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGPMV Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (70% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.14 | +13.21% | ABOVE |
| 50 SMA | $1.27 | +1.64% | ABOVE |
| 100 SMA | $1.30 | -1.07% | BELOW |
| 150 SMA | $1.27 | +1.41% | ABOVE |
| 200 SMA | $1.30 | -0.78% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PMVP in an uptrend right now?
PMVP has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is PMVP overbought or oversold?
PMVP's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is PMVP outperforming the market?
PMVP has a Relative Strength (RS) Rating of 33 out of 99. PMVP is currently lagging the broader market.
Where is PMVP in its 52-week range?
PMVP is trading at $1.29, which is 69% of its 52-week high ($1.88) and 36% above its 52-week low ($0.96).
How volatile is PMVP?
PMVP has a Beta of 0.66 and 52-week volatility of 70%. It's less volatile than the S&P 500 - generally more stable.